어큐먼 파마슈티컬스, Inc.
US ˙ NasdaqGS ˙ US00509G2093

SecurityABOS / Acumen Pharmaceuticals, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership659,675 shares
Latest Disclosed Value $ 1,556,833
Millennium Management Llc ownership in ABOS / Acumen Pharmaceuticals, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 659,675 shares of Acumen Pharmaceuticals, Inc. (US:ABOS) valued at $1,556,833 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 584,143 shares of Acumen Pharmaceuticals, Inc.. This represents a change in shares of 12.93% during the quarter. The current value of the position is $1,418,301 USD.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (ABOS) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ABOS / Acumen Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ACUMEN PHARMACEUTICALS COM 00509G209 659,675 75,532 12.93 1,557 26.30 0.0006
2026-02-17 2025-12-31 13F ACUMEN PHARMACEUTICALS COM 00509G209 584,143 -17,573 -2.92 1,233 19.84 0.0005
2025-11-14 2025-09-30 13F ACUMEN PHARMACEUTICALS COM 00509G209 601,716 -1,348,404 -69.14 1,029 -54.55 0.0004
2025-08-14 2025-06-30 13F ACUMEN PHARMACEUTICALS COM 00509G209 1,950,120 814,898 71.78 2,262 81.25 0.0011
2025-05-15 2025-03-31 13F ACUMEN PHARMACEUTICALS COM 00509G209 1,135,222 -209,523 -15.58 1,249 -46.02 0.0007
2025-02-14 2024-12-31 13F ACUMEN PHARMACEUTICALS COM 00509G209 1,344,745 -490,008 -26.71 2,313 -49.19 0.0011
2024-11-14 2024-09-30 13F ACUMEN PHARMACEUTICALS COM 00509G209 1,834,753 -119,332 -6.11 4,550 -3.76 0.0022
2024-08-14 2024-06-30 13F ACUMEN PHARMACEUTICALS COM 00509G209 1,954,085 -675,456 -25.69 4,729 -55.60 0.0022
2024-05-15 2024-03-31 13F ACUMEN PHARMACEUTICALS COM 00509G209 2,629,541 1,134,257 75.86 10,650 85.49 0.0045
2024-02-14 2023-12-31 13F ACUMEN PHARMACEUTICALS COM 00509G209 1,495,284 -221,006 -12.88 5,742 -19.39 0.0025
2023-11-14 2023-09-30 13F ACUMEN PHARMACEUTICALS COM 00509G209 1,716,290 570,272 49.76 7,123 29.21 0.0036
2023-08-14 2023-06-30 13F ACUMEN PHARMACEUTICALS COM 00509G209 1,146,018 500,135 77.43 5,512 110.22 0.0027
2023-05-15 2023-03-31 13F ACUMEN PHARMACEUTICALS COM 00509G209 645,883 -19,833 -2.98 2,622 -27.07 0.0015
2023-02-14 2022-12-31 13F ACUMEN PHARMACEUTICALS COM 00509G209 665,716 195,224 41.49 3,595 -23.82 0.0020
2022-11-14 2022-09-30 13F ACUMEN PHARMACEUTICALS COM 00509G209 470,492 -117,091 -19.93 4,719 70.85 0.0028
2022-08-15 2022-06-30 13F ACUMEN PHARMACEUTICALS COM 00509G209 587,583 587,583 2,762 0.0017
2022-05-16 2022-03-31 13F ACUMEN PHARMACEUTICALS COM 00509G209 0 -37,163 -100.00 0 -100.00
2022-02-14 2021-12-31 13F ACUMEN PHARMACEUTICALS COM 00509G209 37,163 37,163 251 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-02-14 2023-12-31 13F ACUMEN PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F ACUMEN PHARMACEUTICALS COM Call 53,800 -72.28 223 -76.10 n/a n/a n/a
2023-08-14 2023-06-30 13F ACUMEN PHARMACEUTICALS COM Call 194,100 934 n/a n/a n/a
2023-02-14 2022-12-31 13F ACUMEN PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F ACUMEN PHARMACEUTICALS COM Call 65,000 652 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.